Exploratory research for role of typical protein-bound uremic toxins as a cardiorenal syndrome in patients with acute heart failure and/or acute myocardial infarction.

Exploratory research for role of typical protein-bound uremic toxins as a cardiorenal syndrome in patients with acute heart failure and/or acute myocardial infarction. - TUTORIAL-1 trail

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014375

Enrollment

Registered

2014-07-01

Start date

2014-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute heart failure and/or acute myocardial infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient with acute heart failure and/or acute myocardial infarction who had required urgent hospitalization. 2. Over 20 years old patient, regardless of sex.

Exclusion criteria

Exclusion criteria: 1. Patient who was administered investigational agent within 6 months(180 days). 2. Patient whose prognosis is regarded as less than 12 months. 3. Patient considered to be improper to this study by attending doctor

Design outcomes

Primary

Measure	Time frame
A sequence of blood concentration of typical protein-bound uremic toxins(indoxyl sulfate and p-cresyl sulfate)	—

Secondary

Measure	Time frame
exploratory investigation of relationship between uremic toxins and clinical events after 1 year, physical condition, and other measurements such as renal diameter, laboratory data and so on	—

Countries

Japan

Contacts

Public ContactKunihisa Kohno

Okayama university hospital Department of Cardiovascular Medicine

kunihisakohno@msn.com086-235-7351

Outcome results